Overview

High Intensity Focused Ultrasound (HIFU) Ablation System Study

Status:
Suspended
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the HIFU Pulmonary Vein Ablation System is effective in the treatment of paroxysmal Atrial Fibrillation compared to the control of best medical therapy with FDA approved antiarrhythmic drugs.
Phase:
Phase 3
Details
Lead Sponsor:
ProRhythm, Inc.
Treatments:
Amiodarone
Anti-Arrhythmia Agents
Dofetilide
Flecainide
Propafenone